Senior Director
Revolution Medicines
Senior Director
Revolution Medicines
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Revolution Medicines is seeking an experienced Senior Director, Assistant Treasurer to help lead and scale the Company’s global treasury capabilities during a period of significant growth and increasing international complexity. Reporting to the Treasurer, this individual will play a key role across global liquidity and cash management, cash forecasting, banking, foreign exchange risk management, investments and treasury operations.
This is a highly visible, hands-on role with particular responsibility for developing and executing RevMed’s foreign exchange risk management capabilities and building scalable treasury and banking infrastructure to support the Company’s international expansion. The Senior Director will also partner closely with the Treasurer on insurance and risk management, financing and capital markets activities, and other strategic treasury initiatives.
The successful candidate will bring broad corporate treasury experience, strong technical expertise in foreign exchange and global banking, sound financial judgment, and the ability to move effectively between strategy, analysis and hands-on execution while partnering closely across Finance, Accounting, Tax, Legal and other functions.
Responsibilities:
Oversee global cash and liquidity, including cash positioning, entity funding and liquidity optimization.
Own and continuously enhance short- and medium-term cash forecasting, partnering with FP&A, Accounting and business stakeholders to improve visibility, accuracy and decision-making.
Lead the Company’s foreign exchange risk management activities, including identification and measurement of currency exposures and development of appropriate hedging strategies.
Execute and manage FX hedging activities, including derivative transactions, counterparty relationships, settlements, controls and reporting.
Partner closely with Accounting, FP&A, Tax and other stakeholders on exposure forecasting, hedge accounting and related financial reporting requirements.
Partner with the Treasurer and Tax to build and scale global banking and treasury infrastructure including cash pooling, intercompany funding and bank and investment account architecture.
Manage global bank account administration, including account openings and closures, authorized signers, electronic banking access and related governance.
Develop and enhance treasury policies, procedures and internal controls across all treasury activities while also identifying and implementing opportunities to automate and simplify treasury processes, systems and reporting.
Manage key relationships with global banking partners and evaluate banking products, services and technologies that enhance liquidity, efficiency and control.
Partner with Tax, Legal and Accounting on international entity funding, intercompany cash flows and other cross-border treasury matters.
Support management of the Company’s investment portfolio in accordance with established investment policies, including monitoring liquidity, maturity profile, counterparty exposure and investment performance.
Partner with the Treasurer on the Company’s insurance and risk management programs, including renewals, exposure analysis, broker and carrier relationships, and evaluation of coverage alternatives.
Support the Treasurer on financing, capital markets and other strategic treasury initiatives as needed.
Serve as a trusted treasury partner to Accounting, FP&A, Tax, Legal and other functions, providing clear analysis and practical guidance on financial and treasury matters.
Required Skills, Experience and Education:
Bachelor’s degree in Finance, Accounting, Economics, Business or a related discipline.
12+ years of progressive corporate treasury, finance or related experience, including substantial direct experience across multiple treasury disciplines.
Experience within a publicly traded company strongly preferred; biotechnology, pharmaceutical or broader life sciences industry experience is highly desirable.
Strong experience in foreign exchange risk management, including exposure identification, hedging strategy, execution of FX derivatives, hedge accounting and related reporting.
Deep knowledge of global cash management, liquidity planning, cash forecasting and commercial banking.
Demonstrated success building or expanding international banking structures, treasury systems and controls and addressing associated SOX requirements
Exposure to corporate insurance and risk management programs preferred.
Experience with or meaningful exposure to corporate financing and capital markets activities.
Ability to operate successfully in a fast-paced, evolving environment and balance strategic priorities with hands-on execution.
CTP, CFA, CPA or other relevant professional designations is a plus. MBA preferred.
#LI-TS1 #LI-Remote
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Base Pay Salary Range 232000 - 290000 USD
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.
Explore more opportunities at Revolution Medicines